More about
Secondary Inflammatory Events
News
August 16, 2024
2 min watch
Save
VIDEO: Ixo-vec may reduce need for anti-VEGF injections in wet AMD
In this video, Donald J. D’Amico, MD, discusses data from the phase 2 LUNA trial of Ixo-vec intravitreal gene therapy for neovascular age-related macular degeneration.